MT-125

MT-125 · Myosin Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MT-125, covering 2026-04-14 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1/2 Study of the Safety and Tolerability of MT-125 in GBM Patients [Phase 1, Phase 2]